SIG
IMI

Stanford Investment Group’s Intermolecular, Inc. IMI Stock Holding History

Stanford Investment Group’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67,246
Closed -$64K – 339
2016
Q4 		$64K Buy
67,246
+5,414
+9% +$5.33K 0.03% 123
2016
Q3 		$61K Hold
61,832
– – 0.03% 131
2016
Q2 		$92K Hold
61,832
– – 0.05% 94
2016
Q1 		$156K Buy
61,832
+1,560
+3% +$3.52K 0.09% 65
2015
Q4 		$140K Buy
60,272
+6,193
+11% +$13K 0.08% 77
2015
Q3 		$102K Buy
+54,079
New +$113K 0.08% 79

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Stanford Investment Group's IMI Position: Q1 2017 in Review

Stanford Investment Group sold out of Intermolecular, Inc. (IMI) in Q1 2017, closing a stake of 67,246 shares — an estimated $64K sold.

Stanford Investment Group first reported a position in IMI in Q3 2015 and held it in 6 quarters. The position peaked at $156K in Q1 2016. 25 funds tracked by Wall St. Rank hold IMI as of Q1 2017.

  • Stanford Investment Group reported no remaining Intermolecular, Inc. position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 67,246 Intermolecular, Inc. shares in Q1 2017, an estimated $64K.
  • Stanford Investment Group first reported a position in Intermolecular, Inc. in Q3 2015 and held it in 6 quarters.
  • Stanford Investment Group's Intermolecular, Inc. position peaked at $156K in Q1 2016.
  • 25 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.